{"database": "lobbying", "table": "lobbying_activities", "rows": [[1954735, "f79fb37b-00c0-46e0-a9b7-7445ee594653", "Q1", "KASOWITZ LLP", 401103221, "SPECTRUM PHARMACEUTICALS", 2017, "first_quarter", "MED", "Regulation of the medical use of nuclear materials and its effect on cancer patient access.", "HOUSE OF REPRESENTATIVES,Nuclear Regulatory Commission (NRC),SENATE", 0, 0, "2017-04-17T16:01:05.947000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1954735"], "units": {}, "query_ms": 0.39879995165392756, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}